Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Dec;42(3):1126–1135. doi: 10.1128/iai.42.3.1126-1135.1983

Toxofactor associated with Toxoplasma gondii infection is toxic and teratogenic to mice.

B Grimwood, G O'Connor, H A Gaafar
PMCID: PMC264416  PMID: 6689000

Abstract

A toxin associated with Toxoplasma gondii infection was obtained from the trophozoites and culture medium used to propagate the parasite in cell cultures. The toxin, named Toxofactor (TF), administered parenterally or nonparenterally in adult mice, produces transient symptoms of lethargy, ruffled fur, and body weight loss. Organ changes which accompanied the outward symptoms included hepatosplenomegaly and involuted thymus. TF activity was detected in extracts of the blood, peritoneal fluid, liver, and spleen of infected mice. Severe damage to embryonal and fetal development was induced when TF was administered during pregnancy. Resorption, abortion, and congenital abnormalities were produced, dependent upon the stage of development at the time of exposure. Adult mice which had reacted to and recovered from an initial intraperitoneal injection to TF were protected against a secondary challenge from TF. Fetal development was also protected from damage when TF was used to challenge adults previously exposed to TF. Mouse and rabbit anti-TF sera neutralized TF activity in the adult. In no instance did control mice show any deleterious effect when exposed to soluble cell lysate from the uninfected cell line (BHK-21) used to propagate the organism plus the used medium from these same uninfected cells. TF activity was not attributed to bacterial, myocoplasmal, or viral contamination. TF toxic activity is labile to elevated temperature and high or low pH, which also destroy its protective properties. TF activity was sensitive to trypsin and was obtained in the elution fraction (alpha-methyl-D-mannoside) from affinity chromatography (concanavalin A-Sepharose 4B). Ultrafiltration indicated the molecular weight to be between 50,000 and 100,000. TF, apparently a glycoprotein, was quantitated for activity by a weight loss assay. A unit of activity was defined as the minimum quantity of TF (highest dilution) which produced at least a 10% average body weight loss in adult Nya:NYLAR female mice between days 7 and 12 post-intraperitoneal injection.

Full text

PDF
1126

Images in this article

1131Image
on p.1131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIBILEISHVILI Z. A. K IZUCHENIIU GENERATIVNO I FUNKTSII I STRUKTURNYKH IZMENENI I V IAICHNIAKAKH KROL'CHIKH PRI 'EKSPERIMENTAL'NOM TOKSOPLAZMOZE. Akush Ginekol (Mosk) 1964 Sep-Oct;40:122–125. [PubMed] [Google Scholar]
  2. Buxton D., Gilmour J. S., Angus K. W., Blewett D. A., Miller J. K. Perinatal changes in lambs infected with Toxoplasma gondii. Res Vet Sci. 1982 Mar;32(2):170–176. [PubMed] [Google Scholar]
  3. Dische M. R., Gooch W. M., 3rd Congenital toxoplasmosis. Perspect Pediatr Pathol. 1981;6:83–113. [PubMed] [Google Scholar]
  4. Frenkel J. K. Pathology and pathogenesis of congenital toxoplasmosis. Bull N Y Acad Med. 1974 Feb;50(2):182–191. [PMC free article] [PubMed] [Google Scholar]
  5. GABKA J. Tierexperimentelle Untersuchungen zur Erzeugung von Phänokopien durch Toxoplasmeninfektion. Z Mensch Vererb Konstitutionsl. 1957;34(1):38–76. [PubMed] [Google Scholar]
  6. GIROUD P., GIROUD A., MARTINET M. Avortements et lésions des embryons chez la rate gestante inoculée avec Toxoplasma gondi. Bull Soc Pathol Exot Filiales. 1954;47(4):505–508. [PubMed] [Google Scholar]
  7. Gershman R. N., Kvitnitskii-Ryzhov Iu N. Neiromorfologicheskaia kharakteristika eksperimental'nogo khronicheskogo toksoplazmoza. Arkh Patol. 1972;34(1):35–40. [PubMed] [Google Scholar]
  8. Grimwood B. G., Hechemy K., Stevens R. W. Toxoplasma gondii: purification of trophozoites propagated in cell culture. Exp Parasitol. 1979 Oct;48(2):282–286. doi: 10.1016/0014-4894(79)90110-3. [DOI] [PubMed] [Google Scholar]
  9. Grimwood B. G. Infective Toxoplasma gondii trophozoites attenuated by ultraviolet irradiation. Infect Immun. 1980 May;28(2):532–535. doi: 10.1128/iai.28.2.532-535.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hay J., Hutchison W. M., Lee W. R., Siim J. C. Cataract in mice congenitally infected with Toxoplasma gondii. Ann Trop Med Parasitol. 1981 Aug;75(4):455–457. doi: 10.1080/00034983.1981.11687464. [DOI] [PubMed] [Google Scholar]
  11. Hogan M. J., Moschini G. B., Zardi O. Effects of Toxoplasma gondii toxin on the rabbit eye. Am J Ophthalmol. 1971 Oct;72(4):733–742. doi: 10.1016/0002-9394(71)90011-0. [DOI] [PubMed] [Google Scholar]
  12. Larsen J. W., Jr Congenital toxoplasmosis. Teratology. 1977 Apr;15(2):213–217. doi: 10.1002/tera.1420150212. [DOI] [PubMed] [Google Scholar]
  13. Ruskin J., Remington J. S. Toxoplasmosis in the compromised host. Ann Intern Med. 1976 Feb;84(2):193–199. doi: 10.7326/0003-4819-84-2-193. [DOI] [PubMed] [Google Scholar]
  14. SIIM J. C., BIERING-SORENSEN U. TOXOPLASMOSIS IN DOMESTIC ANIMALS. Adv Vet Sci. 1963;8:335–429. [PubMed] [Google Scholar]
  15. WEINMAN D., KLATCHKO H. J. Description of toxin in toxoplasmosis. Yale J Biol Med. 1950 Mar;22(4):323–326. [PMC free article] [PubMed] [Google Scholar]
  16. Werner H., Masihi K. N., Senk U. Latent toxoplasma-infection as a possible risk factor for CNS-disorders. Zentralbl Bakteriol Mikrobiol Hyg A. 1981 Sep;250(3):368–375. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES